7-n-(4-hydroxyphenyl)mitomycin c has been researched along with Sarcoma 180 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imai, R; Inaba, M; Kobayashi, T; Marumo, H; Morimoto, M; Sakurai, Y; Tsukagoshi, S; Tsuruo, T | 1 |
1 other study(ies) available for 7-n-(4-hydroxyphenyl)mitomycin c and Sarcoma 180
| Article | Year |
|---|---|
Antitumor activity of 7-n-(p-hydroxyphenyl)-mitomycin C in experimental tumor systems.
Topics: Animals; Carcinoma; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fibrosarcoma; Leukemia P388; Lung Neoplasms; Male; Mice; Mice, Inbred Strains; Mitomycin; Mitomycins; Neoplasms, Experimental; Sarcoma 180 | 1981 |